Thursday – Clinical Track 3A Survey

Full Name(Required)
Enter your first and last names as you would like them to appear on your certificates.
Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Topic and Speaker(s)
ExcellentGoodFairPoor
Modeling long-term outcomes for BoNT-A in patients with post-stroke spasticity
Klemens Fheodoroff, MD (Austria)
Online monitoring of long-term spasticity management with BoNT-A
Alexander Geurts, MD, PhD (Netherlands)
Spasticity-related quality of life: Six dimensions instrument (SQoL-6D) in upper limb spasticity
Jorge Jacinto, MD (Portugal)
Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections
Jörg Wissel, MD, FRCP (Germany)
A practical booklet for ultrasound-guided botulinum toxin injections
Stefano Carda, MD (Switzerland)
YesNo
Modeling long-term outcomes for BoNT-A in patients with post-stroke spasticity
Klemens Fheodoroff, MD (Austria)
Online monitoring of long-term spasticity management with BoNT-A
Alexander Geurts, MD, PhD (Netherlands)
Spasticity-related quality of life: Six dimensions instrument (SQoL-6D) in upper limb spasticity
Jorge Jacinto, MD (Portugal)
Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections
Jörg Wissel, MD, FRCP (Germany)
A practical booklet for ultrasound-guided botulinum toxin injections
Stefano Carda, MD (Switzerland)
YesNo
Modeling long-term outcomes for BoNT-A in patients with post-stroke spasticity
Klemens Fheodoroff, MD (Austria)
Online monitoring of long-term spasticity management with BoNT-A
Alexander Geurts, MD, PhD (Netherlands)
Spasticity-related quality of life: Six dimensions instrument (SQoL-6D) in upper limb spasticity
Jorge Jacinto, MD (Portugal)
Choice of shoulder muscles for the multi-pattern treatment of upper limb spasticity with botulinum neurotoxin injections
Jörg Wissel, MD, FRCP (Germany)
A practical booklet for ultrasound-guided botulinum toxin injections
Stefano Carda, MD (Switzerland)
Strongly disagreeDisagreeNeutralAgreeStrongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care